CLASS II ONGOING Device recall · Reported 9 Jul 2025 · FDA Enforcement Report

HardyCHROM CRE, selective and differential culture medium recalled

Hardy Diagnostics is recalling HardyCHROM CRE, selective and differential culture medium for antimicrobial, distributed in 22 states. The recall was initiated on 6 May 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI-DI 008165760257704 G323 lot 653594P: Manufactured on March 6, 2025; Expires on May 15, 2025 G323 lot 655101P: Manufactured on April 4, 2025; Expires on June 13, 2025 G323 lot 656816P: Manufactured on April 16, 2025; Expires on June 25, 2025
Quantity recalled4300 ea

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2041-2025
FDA event ID
96843
Recalling firm
Hardy Diagnostics, Santa Maria, CA
Classification
Class II
Status
Ongoing
Recall initiated
6 May 2025
FDA classified
27 Jun 2025
Reported
9 Jul 2025
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction

Timeline

6 May 2025Recall initiated by company
27 Jun 2025Classified by FDA+52 days
9 Jul 2025Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Identified lots failed incoming quality control testing. Lots exhibited breakthrough growth of Klebsiella pneumoniae.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

HardyCHROM CRE, selective and differential culture medium for antimicrobial susceptibility testing, Product Catalog No. G323

Where it was distributed

US domestic distribution to the following states: AZ, CA, CO, FL, GA, IL, MD, ME, MI, MN, MO, NC, NE, NV, NY, PA, PR, TX, UT, VA, WI and WV.

ArizonaCaliforniaColoradoFloridaGeorgiaIllinoisMarylandMaineMichiganMinnesotaMissouriNorth CarolinaNebraskaNevadaNew YorkPennsylvaniaPuerto RicoTexasUtahVirginia

Questions about this recall

Why was it recalled?

Identified lots failed incoming quality control testing. Lots exhibited breakthrough growth of Klebsiella pneumoniae.

Which lots are affected?

UDI-DI 008165760257704 G323 lot 653594P: Manufactured on March 6, 2025; Expires on May 15, 2025 G323 lot 655101P: Manufactured on April 4, 2025; Expires on June 13, 2025 G323 lot 656816P: Manufactured on April 16, 2025; Expires on June 25, 2025

Where was it sold?

US domestic distribution to the following states: AZ, CA, CO, FL, GA, IL, MD, ME, MI, MN, MO, NC, NE, NV, NY, PA, PR, TX, UT, VA, WI and WV.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Hardy Diagnostics

All 20

Other Other Medical Devices recalls

All 13,908